List of works - Halil Genc

C reactive protein levels in non-alcoholic fatty liver disease

scientific article published on 31 August 2011

Carotid atherosclerosis or nonalcoholic fatty liver disease: which comes first?

scientific article published on 25 September 2013

Chitotriosidase activity predicts endothelial dysfunction in type-2 diabetes mellitus.

scientific article published on 11 April 2010

Choroidal Thickness Changes in the Acute Attack Period in Patients with Familial Mediterranean Fever

scientific article published on 5 December 2015

Circulating levels of interleukin-18 in patients with non-alcoholic fatty liver disease

scientific article published on 01 October 2010

Circulating vaspin and its relationship with insulin sensitivity, adiponectin, and liver histology in subjects with non-alcoholic steatohepatitis

scientific article published on 19 July 2011

Comment and reply on: Serum chemerin and vaspin in non-alcoholic fatty liver disease

scientific article published on 01 August 2010

Efficacy of a modified sequential therapy including bismuth subcitrate as first-line therapy to eradicate Helicobacter pylori in a Turkish population.

scientific article published on 26 August 2012

Elevated asymmetric dimethylarginine in plasma: an early marker for endothelial dysfunction in non-alcoholic fatty liver disease?

scientific article published on 19 December 2011

Hyperuricemia in non-alcoholic fatty liver disease

scientific article published on 01 October 2011

Insulin Resistance but Not Visceral Adiposity Index Is Associated with Liver Fibrosis in Nondiabetic Subjects with Nonalcoholic Fatty Liver Disease.

scientific article

Low- and high-density lipoprotein subclasses in subjects with nonalcoholic fatty liver disease

scientific article

Microalbuminuria and nonalcoholic fatty liver disease

scientific article published on 24 April 2010

Neutrophil-to-lymphocyte ratio is not a predictor of liver histology in patients with nonalcoholic fatty liver disease.

scientific article

Non-invasive prediction of fibrosis in non-alcoholic fatty liver disease

scientific article published on 12 January 2011

Plasma fetuin-A is associated with endothelial dysfunction and subclinical atherosclerosis in subjects with nonalcoholic fatty liver disease.

scientific article published in May 2013

Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance.

scientific article published on 7 September 2006

Platelet aggregation is not enhanced in patients with prediabetes.

scientific article

Soluble CD40 ligand, soluble P-selectin and von Willebrand factor levels in subjects with prediabetes: the impact of metabolic syndrome.

scientific article published on 7 November 2011

The plasma levels of soluble P-selectin in subjects with prediabetes.

scientific article published on September 2006

The presence of MEFV gene mutations in patients with primary osteoarthritis who require surgery.

scientific article published on 14 August 2013

The relationship between blood urea nitrogen levels and metabolic, biochemical, and histopathologic findings of nondiabetic, nonhypertensive patients with nonalcoholic fatty liver disease.

scientific article

The relationship of circulating fetuin-a with liver histology and biomarkers of systemic inflammation in nondiabetic subjects with nonalcoholic fatty liver disease

scientific article published on May 2015

The relationship of serum uric acid with non-alcoholic fatty liver disease

scientific article published on 11 February 2014

List of works by Halil Genc

C reactive protein levels in non-alcoholic fatty liver disease

Carotid atherosclerosis or nonalcoholic fatty liver disease: which comes first?

Chitotriosidase activity predicts endothelial dysfunction in type-2 diabetes mellitus.

Choroidal Thickness Changes in the Acute Attack Period in Patients with Familial Mediterranean Fever

Circulating levels of interleukin-18 in patients with non-alcoholic fatty liver disease

Circulating vaspin and its relationship with insulin sensitivity, adiponectin, and liver histology in subjects with non-alcoholic steatohepatitis

Comment and reply on: Serum chemerin and vaspin in non-alcoholic fatty liver disease

Efficacy of a modified sequential therapy including bismuth subcitrate as first-line therapy to eradicate Helicobacter pylori in a Turkish population.

Elevated asymmetric dimethylarginine in plasma: an early marker for endothelial dysfunction in non-alcoholic fatty liver disease?

Hyperuricemia in non-alcoholic fatty liver disease

Insulin Resistance but Not Visceral Adiposity Index Is Associated with Liver Fibrosis in Nondiabetic Subjects with Nonalcoholic Fatty Liver Disease.

Low- and high-density lipoprotein subclasses in subjects with nonalcoholic fatty liver disease

Microalbuminuria and nonalcoholic fatty liver disease

Neutrophil-to-lymphocyte ratio is not a predictor of liver histology in patients with nonalcoholic fatty liver disease.

Non-invasive prediction of fibrosis in non-alcoholic fatty liver disease

Plasma fetuin-A is associated with endothelial dysfunction and subclinical atherosclerosis in subjects with nonalcoholic fatty liver disease.

Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance.

Platelet aggregation is not enhanced in patients with prediabetes.

Soluble CD40 ligand, soluble P-selectin and von Willebrand factor levels in subjects with prediabetes: the impact of metabolic syndrome.

The plasma levels of soluble P-selectin in subjects with prediabetes.

The presence of MEFV gene mutations in patients with primary osteoarthritis who require surgery.

The relationship between blood urea nitrogen levels and metabolic, biochemical, and histopathologic findings of nondiabetic, nonhypertensive patients with nonalcoholic fatty liver disease.

The relationship of circulating fetuin-a with liver histology and biomarkers of systemic inflammation in nondiabetic subjects with nonalcoholic fatty liver disease

The relationship of serum uric acid with non-alcoholic fatty liver disease